HSV-1 amplicon vectors as genetic vaccines

Area of Science:

• Virology
• Vaccinology
• Molecular Biology

Background:

• Herpes simplex virus type 1 (HSV-1) amplicon vectors are established platforms for genetic vaccine development.
• Previous studies demonstrated partial protection against foot-and-mouth disease virus and rotavirus using these vectors.

Purpose of the Study:

• To describe the use of HSV-1 amplicon vectors for expressing individual or multiple viral structural proteins.
• To investigate the in situ production of virus-like particles (VLPs) from these vectors in mammalian cells.

Main Methods:

• Utilizing HSV-1 amplicon vectors with polycistronic transgene cassettes to express viral structural proteins.
• Confirming viral gene expression via Western blot and immunofluorescence analysis.
• Demonstrating VLP generation using electron microscopy.

Main Results:

• HSV-1 amplicon vectors successfully expressed individual and multiple viral structural proteins.
• Vectors encoding multiple proteins facilitated the in situ production of VLPs within infected cells.
• Expression and VLP formation were validated through biochemical and microscopic techniques.

Conclusions:

• HSV-1 amplicon vectors are effective tools for the expression of viral structural proteins and the assembly of VLPs.
• This approach supports the development of complex and safe genetic vaccines.
• The technology holds potential for creating novel vaccine strategies against various viral pathogens.